Single vs multiple radiation doses for cancer spread
Part of Cancer, Digestive system, Kidney & urinary, Skin clinical trials.
This trial compares a single, strong dose of radiation to multiple smaller doses for treating cancer that has spread to a few spots. It aims to see which approach causes fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- All your active cancer spots have been or will be treated with a goal to cure (surgery or radiation).
- All spots you'll get radiation on can safely handle a single, strong dose.
- You can be on other cancer treatments at the same time.
- You must agree to be part of the main study and possibly randomized to this sub-study.
- Your targeted metastases are not too close to sensitive organs like the spine, stomach, or major airways.
- No single metastasis is larger than 5 cm (about 2 inches).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
This trial tests whether giving one strong dose of radiation is as good as several smaller doses for people with a small number of cancer spots that have spread. The goal is to find a treatment that is just as effective but more convenient and with fewer side effects.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial tests a faster way to give radiation to people with a few spots of cancer that have spread. They use a special scan to plan treatment right away, so you may not need a separate planning visit.
This trial tests whether giving immune-supporting cells (lymphocytes) alongside focused radiation (SBRT) can help control limited cancer spread. People with 1 to 5 small tumors that can all be radiated within two weeks may be eligible.
This trial compares two types of radiation for people whose cancer has spread to a few new spots while on or after treatment. It tests whether a precise, high-dose radiation approach (stereotactic) works better than the usual palliative radiation for controlling these growing spots.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.